Rutherford-based Cancer Genetics, an emerging DNA-based diagnostics, announced Monday it has appointed Edward J. Sitar, CPA as chief financial officer effective April 1, 2014.
According to the announcement, Sitar will be responsible for all corporate finance and accounting activities for the company.
He was most recently CFO of Healthagen, a subsidiary of Aetna. Prior to that, he was the executive vice president and CFO of ActiveHealth Management, also a subsidiary of Aetna.
The company also announced the resignation of Elizabeth Adkins Czerepak, CFO and principal accounting officer, effective March 31, 2014, the announcement said.
ALSO ON NJBIZ: